The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RAINBOW-Asia: A randomized, multicenter, double-blind, phase III study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in the treatment of advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line chemotherapy with platinum and fluoropyrimidine.
 
Rui-hua Xu
No Relationships to Disclose
 
Yan-Qiao Zhang
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Ji Feng Feng
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Tianshu Liu
No Relationships to Disclose
 
Yanru Qin
No Relationships to Disclose
 
Rubing Han
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Wanli Zhang
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Lin Shen
No Relationships to Disclose